Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLX-PAD for muscle injury following hip fracture arthroplasty
2017-005165-49Phase 3Terminated
- Sponsor
- Pluri Inc.
- Start
- Apr 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of PLX-PAD in muscle strain, sponsored by Pluri Inc.. Started Apr 2018; status: terminated.
02
Drugs
PLX-PAD
03
Conditions
muscle strain
Beyond the preview
Go deeper on 2017-005165-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005165-49.